Bart Vrijsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bart Vrijsen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Bertien Buyse
Leuven University Centre of Sleep/wake disorders, University Hospitals Leuven, Leuven, Belgium
7 shared publicationsCatharina Belge
A Department of Pulmonology and Leuven University Centre for Sleep and Wake disorders (LUCS) - University Hospitals Leuven
4 shared publications- Dries Testelmans
Department of Pulmonology, University Hospitals Leuven, Leuven, Belgium
4 shared publications Dries Testelmans
A Department of Pulmonology and Leuven University Centre for Sleep and Wake disorders (LUCS) - University Hospitals Leuven
3 shared publications- Philip Van Damme
Laboratory of Neurobiology, Department of Neuroscience, KU Leuven, Leuven, Belgium
3 shared publications Wim Robberecht
Department of Neurology, University of Leuven, Belgium
2 shared publications
Latest Publications
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Introduction: Patients with obstructive sleep apnea (OSA) are less physically active compared to controls. Studies evaluating the effect of continuous positive airway pressure (CPAP) on physical activity (PA) showed inconsistent findings. Aims: We performed a RCT to compare the effect of CPAP with and without telecoaching on PA in OSA patients with a mean number of steps <7500/day. Methods: Patients were randomly allocated to either standard care (CPAP) or the intervention (CPAP with telecoaching). This 12-week intervention aimed to increase the steps/day. A step counter, connected with a smartphone application provided feedback and encouragement. PA was assessed using accelerometry during one week before randomization and after 12 weeks. Secondary outcomes included functional exercise capacity, quality of life (SF-36) and sleep quality (Pittsburgh Sleep Quality index). Results: Fifteen patients (8 intervention) were analyzed. In both groups, subjective feeling of energy increased. No difference in increase of steps/day was observed between and within groups. Functional exercise capacity increased in the intervention group. Sleep quality improved in the total group but without difference between groups. Discussion: CPAP treatment improved subjective feeling of energy and sleep quality. Telecoaching had an effect on functional exercise capacity, although no significant difference was found in steps/day.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Introduction: Patients with obstructive sleep apnea (OSA) are less physically active compared to controls. Studies evaluating the effect of continuous positive airway pressure (CPAP) on physical activity (PA) showed inconsistent findings. Aims: We performed a RCT to compare the effect of CPAP with and without telecoaching on PA in OSA patients with a mean number of steps <7500/day. Methods: Patients were randomly allocated to either standard care (CPAP) or the intervention (CPAP with telecoaching). This 12-week intervention aimed to increase the steps/day. A step counter, connected with a smartphone application provided feedback and encouragement. PA was assessed using accelerometry during one week before randomization and after 12 weeks. Secondary outcomes included functional exercise capacity, quality of life (SF-36) and sleep quality (Pittsburgh Sleep Quality index). Results: Fifteen patients (8 intervention) were analyzed. In both groups, subjective feeling of energy increased. No difference in increase of steps/day was observed between and within groups. Functional exercise capacity increased in the intervention group. Sleep quality improved in the total group but without difference between groups. Discussion: CPAP treatment improved subjective feeling of energy and sleep quality. Telecoaching had an effect on functional exercise capacity, although no significant difference was found in steps/day.
- 15 August 2016
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 12 (8) , 1203-1204
And the Doctor Continues: “…But I Have to Choose My Gear Wisely”
- 15 August 2016
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 12 (8) , 1203-1204
And the Doctor Continues: “…But I Have to Choose My Gear Wisely”
- 14 April 2016
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 17 (5-6) , 343-350
Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis
Sleeping with non-invasive ventilation (NIV) in amyotrophic lateral sclerosis appears to be accompanied by a high patient-ventilator asynchrony (PVA) index. This prospective observational cohort study quantifies PVA and leaks, and searches for effects of these events on sleep after polysomnographic NIV titration. Full-video polysomnography, with incorporation of transcutaneous carbon dioxide and ventilator software, was used to analyse sleep epoch-by-epoch and respiratory events and PVA breath-by-breath in 35 patients (17 non-bulbar). After diagnostic polysomnography, NIV was titrated during three consecutive nights. Sleep, PVA and leaks were evaluated at discharge and after one month. Results showed that non-bulbar patients improved in sleep architecture and oxygen and carbon dioxide levels while bulbar patients only improved oxygen saturation. PVA remained present at discharge (non-bulbar 54 (21–101) and bulbar 31 (9–39)/h sleep) and one month (non-bulbar 31 (9–39) and bulbar 32 (17–55)/h sleep), with ineffective effort as most prominent asynchrony. Leaks also persisted after titration (non-bulbar 16.6 (3.1–44.6) and bulbar 5.1 (0.0–19.5)% of total sleep time (TST)) and one month (non-bulbar 7.7 (1.4–29.3) and bulbar 12.7 (0.0–35.2)% TST). PVA and leaks have none to minor effect on sleep architecture. In conclusion, although PVA and leaks remain present after meticulous NIV titration, these events seem not to interfere with sleep.
- 14 April 2016
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 17 (5-6) , 343-350
Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis
Sleeping with non-invasive ventilation (NIV) in amyotrophic lateral sclerosis appears to be accompanied by a high patient-ventilator asynchrony (PVA) index. This prospective observational cohort study quantifies PVA and leaks, and searches for effects of these events on sleep after polysomnographic NIV titration. Full-video polysomnography, with incorporation of transcutaneous carbon dioxide and ventilator software, was used to analyse sleep epoch-by-epoch and respiratory events and PVA breath-by-breath in 35 patients (17 non-bulbar). After diagnostic polysomnography, NIV was titrated during three consecutive nights. Sleep, PVA and leaks were evaluated at discharge and after one month. Results showed that non-bulbar patients improved in sleep architecture and oxygen and carbon dioxide levels while bulbar patients only improved oxygen saturation. PVA remained present at discharge (non-bulbar 54 (21–101) and bulbar 31 (9–39)/h sleep) and one month (non-bulbar 31 (9–39) and bulbar 32 (17–55)/h sleep), with ineffective effort as most prominent asynchrony. Leaks also persisted after titration (non-bulbar 16.6 (3.1–44.6) and bulbar 5.1 (0.0–19.5)% of total sleep time (TST)) and one month (non-bulbar 7.7 (1.4–29.3) and bulbar 12.7 (0.0–35.2)% TST). PVA and leaks have none to minor effect on sleep architecture. In conclusion, although PVA and leaks remain present after meticulous NIV titration, these events seem not to interfere with sleep.
- 1 January 2016
- Published by Springer Nature
- p. 339-344
Noninvasive Ventilation in Amyotrophic Lateral Sclerosis: Key Technical and Practical Applications
- 1 January 2016
- Published by Springer Nature
- p. 339-344
Noninvasive Ventilation in Amyotrophic Lateral Sclerosis: Key Technical and Practical Applications
- 15 May 2015
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 11 (5) , 559-566
Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study
To evaluate the effects of noninvasive ventilation (NIV) on sleep in patients with amyotrophic lateral sclerosis (ALS) after meticulous titration with polysomnography (PSG). In this prospective observational study, 24 ALS patients were admitted to the sleep laboratory during 4 nights for in-hospital NIV titration with PSG and nocturnal capnography. Questionnaires were used to assess subjective sleep quality and quality of life (QoL). Patients were readmitted after one month. In the total group, slow wave sleep and REM sleep increased and the arousal-awakening index improved. The group without bulbar involvement (non-bulbar) showed the same improvements, together with an increase in sleep efficiency. Nocturnal oxygen and carbon dioxide levels improved in the total and non-bulbar group. Except for oxygen saturation during REM sleep, no improvement in respiratory function or sleep structure was found in bulbar patients. However, these patients showed less room for improvement. Patient-reported outcomes showed improvement in sleep quality and QoL for the total and non-bulbar group, while bulbar patients only reported improvements in very few subscores. This study shows an improvement of sleep architecture, carbon dioxide, and nocturnal oxygen saturation at the end of NIV titration and after one month of NIV in ALS patients. More studies are needed to identify the appropriate time to start NIV in bulbar patients. Our results suggest that accurate titration of NIV by PSG improves sleep quality. A commentary on this article appears in this issue on page 511.
- 15 May 2015
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 11 (5) , 559-566
Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study
To evaluate the effects of noninvasive ventilation (NIV) on sleep in patients with amyotrophic lateral sclerosis (ALS) after meticulous titration with polysomnography (PSG). In this prospective observational study, 24 ALS patients were admitted to the sleep laboratory during 4 nights for in-hospital NIV titration with PSG and nocturnal capnography. Questionnaires were used to assess subjective sleep quality and quality of life (QoL). Patients were readmitted after one month. In the total group, slow wave sleep and REM sleep increased and the arousal-awakening index improved. The group without bulbar involvement (non-bulbar) showed the same improvements, together with an increase in sleep efficiency. Nocturnal oxygen and carbon dioxide levels improved in the total and non-bulbar group. Except for oxygen saturation during REM sleep, no improvement in respiratory function or sleep structure was found in bulbar patients. However, these patients showed less room for improvement. Patient-reported outcomes showed improvement in sleep quality and QoL for the total and non-bulbar group, while bulbar patients only reported improvements in very few subscores. This study shows an improvement of sleep architecture, carbon dioxide, and nocturnal oxygen saturation at the end of NIV titration and after one month of NIV in ALS patients. More studies are needed to identify the appropriate time to start NIV in bulbar patients. Our results suggest that accurate titration of NIV by PSG improves sleep quality. A commentary on this article appears in this issue on page 511.
- 15 September 2014
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 10 (9) , 1033-1035
Upper Airway Obstruction during Noninvasive Ventilation Induced by the Use of an Oronasal Mask
In patients with neuromuscular disorders, no randomized studies have been performed whether nasal or oronasal masks should be preferred. Oronasal masks are often used in acute respiratory failure, while nasal masks are preferred in patients with chronic respiratory failure. However, the use of nasal masks can result in mouth leaks with implications on sleep quality. To reduce these leaks, oronasal masks have been applied during home noninvasive ventilation (NIV). Until now, upper airway obstruction during NIV has been thought to be induced by nasal obstruction, pharyngeal collapse, and/or glottis closure. We report a case indicating another cause of upper airway obstruction: use of an oronasal mask can induce obstructive events in the upper airways, possibly resulting in sleep fragmentation and decreased efficiency of NIV.
- 15 September 2014
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 10 (9) , 1033-1035
Upper Airway Obstruction during Noninvasive Ventilation Induced by the Use of an Oronasal Mask
In patients with neuromuscular disorders, no randomized studies have been performed whether nasal or oronasal masks should be preferred. Oronasal masks are often used in acute respiratory failure, while nasal masks are preferred in patients with chronic respiratory failure. However, the use of nasal masks can result in mouth leaks with implications on sleep quality. To reduce these leaks, oronasal masks have been applied during home noninvasive ventilation (NIV). Until now, upper airway obstruction during NIV has been thought to be induced by nasal obstruction, pharyngeal collapse, and/or glottis closure. We report a case indicating another cause of upper airway obstruction: use of an oronasal mask can induce obstructive events in the upper airways, possibly resulting in sleep fragmentation and decreased efficiency of NIV.
- Open Access
- 19 April 2013
- Published by Springer Nature in Respiratory Research
- Vol. 14 (1) , 1-8
Impact of exacerbations of cystic fibrosis on muscle strength
Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity.
- 19 April 2013
- Published by Springer Nature in Respiratory Research
- Vol. 14 (1) , 1-8
Open AccessImpact of exacerbations of cystic fibrosis on muscle strength
Adult patients with cystic fibrosis have peripheral muscle weakness, which is related to exercise intolerance and poor prognosis. The influence of acute exacerbations on muscle strength has been poorly studied. This study aimed to investigate whether quadriceps force (QF), as assessed with an involuntary technique, changes during intravenous antibiotics therapy (IVAT) for an exacerbation. QF was measured in 20 patients using twitch stimulation of the femoral nerve at the day of hospitalization (day 1) and at termination (day 14) of the IVAT. Physical activity was monitored during IVAT using a SenseWear armband. Ten stable patients served as control subjects. QF did not change during exacerbation (potentiated twitch force at day 1: 140 ± 42 N, at day 14: 140 ± 47 N), but a decrease was observed in individual patients. Changes in twitch force during exacerbation were correlated with time spent in activities of at least moderate intensity (r = 0.61, p = 0.007). QF does not systematically decrease during exacerbations of cystic fibrosis. Individual changes in QF are well correlated with daily time spent in activities of at least moderate intensity.
- 4 January 2013
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 14 (2) , 85-95
Non-invasive ventilation in amyotrophic lateral sclerosis
Non-invasive ventilation (NIV) is widely used to improve alveolar hypoventilation in amyotrophic lateral sclerosis. Several studies indicate a better survival when NIV is used, certainly in patients with none to moderate bulbar dysfunction. Data on quality of life (QoL) are rather disputable. Overall QoL is shown to be equivalent in patients with or without NIV, although health-related QoL is shown to be increased in patients with none to moderate bulbar dysfunction. NIV improves sleep quality, although patient-ventilator asynchronies are demonstrated. FVC < 50%, seated or supine, has been widely applied as threshold to initiate NIV. Today, measurements of respiratory muscle strength, nocturnal gas exchange and symptomatic complaints are used as indicators to start NIV. Being compliant with NIV therapy increases QoL and survival. Cough augmentation has an important role in appropriate NIV. Patients have today more technical options and patients with benefit from these advances are growing in number. Tracheal ventilation needs to be discussed when NIV seems impossible or becomes insufficient.
- 4 January 2013
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 14 (2) , 85-95
Non-invasive ventilation in amyotrophic lateral sclerosis
Non-invasive ventilation (NIV) is widely used to improve alveolar hypoventilation in amyotrophic lateral sclerosis. Several studies indicate a better survival when NIV is used, certainly in patients with none to moderate bulbar dysfunction. Data on quality of life (QoL) are rather disputable. Overall QoL is shown to be equivalent in patients with or without NIV, although health-related QoL is shown to be increased in patients with none to moderate bulbar dysfunction. NIV improves sleep quality, although patient-ventilator asynchronies are demonstrated. FVC < 50%, seated or supine, has been widely applied as threshold to initiate NIV. Today, measurements of respiratory muscle strength, nocturnal gas exchange and symptomatic complaints are used as indicators to start NIV. Being compliant with NIV therapy increases QoL and survival. Cough augmentation has an important role in appropriate NIV. Patients have today more technical options and patients with benefit from these advances are growing in number. Tracheal ventilation needs to be discussed when NIV seems impossible or becomes insufficient.